Do you recommend adjuvant chemoradiation for T2N0 gastric adenocarcinoma?   

In a patient with an R0 resection, would you routinely recommend postop chemoradiation, since these patients were included in the MacDonald trial? Does the degree of lymph node dissection (D0 or D1) affect your recommendation? Does the toxicity outweigh the potential benefit?



Answer from: Radiation Oncologist at Community Practice